DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20161505

Awareness about generic drug prescription amongst practitioners: a knowledge attitude practice survey at rural set up

Jyoti Ramchandra Patil, Swapnil Chudaman Jaykare, Vijay Motiram Motghare, Sudhir Laxmanrao Padwal, Vinod Shivajirao Deshmukh

Abstract


Background: to evaluate the knowledge, attitude and practices regarding generic drugs prescription and the factors influencing it amongst practitioners at a rural set up.

Methods: All the practitioners in the town, at both government and private settings were interviewed individually and the data was collected with the help of a self-administered, pre-validated and semi-structured questionnaire. Data were analysed to describe all variables and test any significant difference between the practitioners at government and private set-up.

Results: The study included 97 practitioners from different affiliations with a response rate of 87.63%. Our survey showed that most of the practitioners (74.36%) were in favour of generic drugs substitution owing to their knowledge about generics. Majority of the practitioners (69.10%) were aware that both the brand and generic drugs are bioequivalent and that there exits significant price difference between them, yet, concerns regarding the manufacturing standards of the latter, prevented them from practicing generic substitution. Practitioners did not report a significant pressure from patients to prescribe either brand or generic drugs. Most practitioners (76.92%) had a positive attitude towards the government’s role in assuring the quality of generic drugs by improving manufacturing standards of these drugs.

Conclusions: Although the practitioners were strongly in favour of generic substitution, concern regarding their quality standards is discouraging them from doing the same. The government can play a major role by improving the standard operating procedures for manufacturing the generic drugs thereby assuring the practitioners about their quality.


Keywords


Generic drugs, Generic substitution, Practitioners, Quality standards

Full Text:

PDF

References


Shrank WH, Stedman M, Ettner SL, DeLapp D, Dirstine J, Brookhart MA, et al. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med. 2007;22:1298-04.

King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43:462-9.

Tsiantou V, Zavras D, Kousoulakou H, Geitona M, Kyriopoulos J. Generic medicines: Greek physicians’ perceptions and prescribing practices. J Clin Pharm Ther. 2009;34:547-54.

Walley T, Earl-Slater A, Haycox A, Bagust A. An integrated national pharmaceutical policy for the United Kingdom? Brit Med J. 2000;321:1523-6.

Alghasham AA. Generic drug prescribing in central Saudi Arabia: Perceptions and attitudes of practitioners. Ann Saudi Med. 2009;29:24-9.

Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy. 2010;95:229-35.

Sharrad AK, Hassali MA, Shafie AA. Generic medicines: perception of physicians in Basrah, Iraq. Am Med J. 2009;1:58-64.

Kersnik J, Peklar J. Attitudes of slovene general practitioners towards generic drug prescribing and comparison with international studies. J Clin Pharm Ther. 2006;31:577-83.

Calvillo JAR, Lana A, Cueto A, Markham WA, Lopez ML. Psychosocial factors associated with the prescription of generic drugs. Health Policy. 2011;101:178-84.

Anonymous. The generic drug scandal. Major events during the generic drug investigations. Am Pharm. 1990;30(7):38-9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/2363392.

Hottinger M, Liang BA. Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs. Am J Law Med. 2012;38:667-89.

Paveliu MS, Bengea S, Paveliu FS. Generic substitution issues: brand-generic substitution, generic-generic substitution, and generic substitution of narrow therapeutic index (NTI)/critical dose drugs. Maedica. 2011;6:52-8.

Singal GL, Nanda A, Kotwani A. A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India. Indian J Pharmacol. 2011;43:131-6.

Jan Aushadhi. An initiative of department of pharmaceuticals, government of India. Available at janaushadhi.gov.in/aushadhi_1.htm. Accessed 2 March 2013.

Direction under 33P - central drugs standard control organization. Annexure A. 2012 Available at www.cdsco.nic.in/direction%20under%2033P.pdf‎. Accessed 12 October 2012.